STAT+: Blood pressure tech floods the market after FDA relaxes wearables oversight

The FDA relaxed oversight on wellness wearables, allowing products to market blood pressure and glucose readings without approval if labeled for wellness. Companies like Oura and Samsung have launched new features, while startups like Pin Pulse raise funds for similar devices. Experts warn of unproven technology risks despite potential benefits for hypertension awareness.